These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 30887626

  • 1. Protective effects and mechanisms of omega-3 polyunsaturated fatty acid on intestinal injury and macrophage polarization in peritoneal dialysis rats.
    Tang H, Zhu X, Gong C, Liu H, Liu F.
    Nephrology (Carlton); 2019 Oct; 24(10):1081-1089. PubMed ID: 30887626
    [Abstract] [Full Text] [Related]

  • 2. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
    Hong M, Nie Z, Chen Z, Yu X, Bao B.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(6):598-606. PubMed ID: 28247603
    [Abstract] [Full Text] [Related]

  • 3. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, Maruyama S, Takei Y, Ito Y.
    Am J Physiol Renal Physiol; 2018 Feb 01; 314(2):F167-F180. PubMed ID: 28978530
    [Abstract] [Full Text] [Related]

  • 4. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
    Zhang L, Hao JB, Ren LS, Ding JL, Hao LR.
    Lab Invest; 2014 Aug 01; 94(8):839-50. PubMed ID: 24862968
    [Abstract] [Full Text] [Related]

  • 5. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
    Li Q, Zheng M, Liu Y, Sun W, Shi J, Ni J, Wang Q.
    Mol Immunol; 2018 Feb 01; 94():131-139. PubMed ID: 29306153
    [Abstract] [Full Text] [Related]

  • 6. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
    Zhao JL, Zhang T, Shao X, Zhu JJ, Guo MZ.
    BMC Complement Altern Med; 2019 Oct 23; 19(1):280. PubMed ID: 31647008
    [Abstract] [Full Text] [Related]

  • 7. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
    Subeq YM, Ke CY, Lin NT, Lee CJ, Chiu YH, Hsu BG.
    Cytokine; 2011 Feb 23; 53(2):223-30. PubMed ID: 21129996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.
    Balzer MS, Helmke A, Ackermann M, Casper J, Dong L, Hiss M, Kiyan Y, Rong S, Timrott K, von Vietinghoff S, Wang L, Haller H, Shushakova N.
    Nephrol Dial Transplant; 2019 Jun 01; 34(6):947-960. PubMed ID: 30247663
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E, Liappas G, Vila Cuenca M, Keuning ED, Foster TL, Vervloet MG, Lopéz-Cabrera M, Beelen RH.
    Kidney Int; 2016 Mar 01; 89(3):625-35. PubMed ID: 26880457
    [Abstract] [Full Text] [Related]

  • 12. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
    Li L, Shen N, Wang N, Wang W, Tang Q, Du X, Carrero JJ, Wang K, Deng Y, Li Z, Lin H, Wu T.
    Kidney Int; 2018 Jun 01; 93(6):1384-1396. PubMed ID: 29571940
    [Abstract] [Full Text] [Related]

  • 13. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
    Chunming J, Miao Z, Cheng S, Nana T, Wei Z, Dongwei C, Yuan F.
    Ren Fail; 2011 Jun 01; 33(3):355-62. PubMed ID: 21401363
    [Abstract] [Full Text] [Related]

  • 14. Role of CIP4 in high glucose induced epithelial--mesenchymal transition of rat peritoneal mesothelial cells.
    Zhang J, Bi M, Zhong F, Jiao X, Zhang D, Dong Q.
    Ren Fail; 2013 Aug 01; 35(7):989-95. PubMed ID: 23819628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
    Zhou X, Chen H, Shi Y, Li J, Ma X, Du L, Hu Y, Tao M, Zhong Q, Yan D, Zhuang S, Liu N.
    Front Immunol; 2023 Aug 01; 14():1137332. PubMed ID: 36911746
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.